HALOPERIDOL TREATMENT WITH CHRONICALLY MEDICATED RESIDENTS: DOSE EFFECTS ON CLINICAL BEHAVIOR AND REINFORCEMENT CONTINGENCIES
Saved in:
AMAN, M.G., ET AL., HALOPERIDOL TREATMENT WITH CHRONICALLY MEDICATED RESIDENTS: DOSE EFFECTS ON CLINICAL BEHAVIOR AND REINFORCEMENT CONTINGENCIES. AMERICAN JOURNAL ON MENTAL RETARDATION, Vol. 93, no. 4 (1989), p. 452-460.
Ref.
10622
Location:
SIIS R.100 Depósito (3)
Palabras clave:
Conducta, Discapacidad, Discapacidad intelectual, Fármacos, Personalidad, Tratamiento
Conducta, Discapacidad, Discapacidad intelectual, Fármacos, Personalidad, Tratamiento
Similar Items: HALOPERIDOL TREATMENT WITH CHRONICALLY MEDICATED RESIDENTS: DOSE EFFECTS ON CLINICAL BEHAVIOR AND REINFORCEMENT CONTINGENCIES
- THIORIDAZINE DOSE EFFECTS WITH REFERENCE TO STEREOTYPIC BEHAVIOR IN MENTALLY RETARDED RESIDENTS
- THE EFFECT OF NONCONTINGENT SENSORY REINFORCEMENT, CONTINGENT SENSORY REINFORCEMENT, AND RESPONSE INTERRUPTION ON STEREOTYPICAL AND SELF-INJURIOUS BEHAVIOR
- CONTINGENT METHADONE TAKE-HOME DOSES REINFORCE ADJUNCT THERAPY ATTENDANCE OF METHADONE MAINTENANCE PATIENTS
- THE EFFECTS OF HALOPERIDOL ON DISCRIMINATION LEARNING AND BEHAVIORAL SYMPTOMSIN AUTISTIC CHILDREN
- THE ABERRANT BEHAVIOR CHECKLIST: A BEHAVIOR RATING SCALE FOR THE ASSESSMENT OF TREATMENT EFFECTS
- Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification